PL
 |
EN

PL EN

Preferencje help
Polish version English version Język
Widoczny [Schowaj] Abstrakt
Liczba wyników
Powiadomienia systemowe
  • Sesja wygasła!
Tytuł artykułu

Bioanalytical methods and extraction techniques for the quantification of hydrochlorothiazide and its pharmaceutical combinations : A comprehensive review

Autorzy
Chakraborty Atyurmila , Jayaseelan Kavitha , Rathinam Seetharaman , Kokilambigai K. S. , Nethra K.
Wybrane pełne teksty z tego czasopisma
Identyfikatory
DOI
10.1556/1326.2023.01187
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Hydrochlorothiazide has been utilized clinically for the past half-century, which is popularly known as a “water pill” as it produces increased urine output. The advancement of bioanalytical methods brought a dynamic field with exciting opportunities for future research. The current review emphasis the bioanalytical methods employed for the quantitative estimation of Hydrochlorothiazide as monotherapy and its popularly used combinational medications available from 1956 to till date. A fixed dose of 25 mg of hydrochlorothiazide with 43 combinational medications is currently available in the market and these combinations are widely employed in the treatment of hypertensive people; those whose blood pressure does not respond effectively to monotherapy of hydrochlorothiazide and also for the treatment of edema (excess fluid in the body) caused by illness such as heart failure, liver problems, and renal disease. It has been convincingly demonstrated that the combination of any two antihypertensive medications belonging to different groups of the same category, significantly lowers blood pressure, in comparison with the effect produced by increasing the dose of a single medicament. Among the various analytical techniques employed for the estimation of Hydrochlorothiazide, the review portrays that hyphenated technique, in specific liquid chromatography coupled with mass spectroscopy was widely employed. The validation parameters namely linearity, LOD, LOQ for individual drug and their combinations, were successfully calibrated. The effectiveness of analytical approaches was evaluated and enhanced for chemical factors. The involvement of green chemistry in the optimized methods for the evaluation of Hydrochlorothiazide for the future development, are suggested.
Słowa kluczowe
EN
Wydawca
University of Silesia in Katowice
Akademiai Kiado
Czasopismo
Acta Chromatographica
Rocznik
2024
Tom
Vol. 36, no. 4
Strony
307--332
Opis fizyczny
Bibliogr. 121 poz., rys., tab., wykr.
Twórcy
autor
Chakraborty Atyurmila
  • Department of Pharmaceutical Analysis, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur - 603 203, Chengalpattu District, Tamil Nadu, India
autor
Jayaseelan Kavitha
kavithaj@srmist.edu.in
  • Department of Pharmaceutical Analysis, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur - 603 203, Chengalpattu District, Tamil Nadu, India
autor
Rathinam Seetharaman
  • Department of Pharmaceutical Analysis, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur - 603 203, Chengalpattu District, Tamil Nadu, India
autor
Kokilambigai K. S.
  • Department of Pharmaceutical Analysis, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur - 603 203, Chengalpattu District, Tamil Nadu, India
autor
Nethra K.
  • Department of Pharmaceutical Analysis, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur - 603 203, Chengalpattu District, Tamil Nadu, India
Bibliografia
  • 1. Lloyd-Jones, D. Heart disease and stroke statistics — 2009 update a report from the American Heart Association Statistics Committee. Am. Hear. Assoc. 2009, 119, 21–181. https://doi.org/10.1161/circulationaha.108.191261.
  • 2. Roush, G. C.; Sica, D. A. Diuretics for hypertension: a review and update. Am. J. Hypertens. 2016, 29(10), 1130–7. https://doi.org/10.1093/ajh/hpw030.
  • 3. Borghi, C.; Omboni, S. Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update. Expert Rev. Cardiovasc. Ther. 2014. https://doi.org/10.1586/14779072.2014.946405.
  • 4. Sanphui, P.; Devi, V. K.; Clara, D.; Malviya, N.; Ganguly, S.; Desiraju, G. R. Cocrystals of hydrochlorothiazide: solubility and diffusion/permeability enhancements through drug-coformer interactions. Mol. Pharm. 2015, 12(5), 1615–22. https://doi.org/10.1021/acs.molpharmaceut.5b00020.
  • 5. Sharma, R. K.; Bansal, V.; Mittal, A.; Sharma, M. Preparation and characterization of immediate releasefilm coated tablets of. Eur. J. Mol. Clin. Med. 2020, 07, 2915–48.
  • 6. Sanphui, P.; Rajput, L. Tuning solubility and stability of hydrochloro-thiazide co-crystals. Acta Crystallogr. Sect. B Struct. Sci. Cryst. Eng. Mater. 2014, 70(1), 81–90. https://doi.org/10.1107/S2052520613026917.
  • 7. Drugs and Lactation Database; LactMed, Bethesda, No. Md, pp. 1–3, 2018, [Online]. Available: https://www.ncbi.nlm.nih.gov/books/.
  • 8. Barrett, W. E.; Rutledge, R. A.; Sheppard, H.; Plummer, A. J. The pharmacology of hydrochlorothiazide (EsidrixTM), a new, orally effective sulfonamide diuretic. Toxicol. Appl. Pharmacol. 1959, 1(4), 333–49. https://doi.org/10.1016/0041-008X(59)90155-3.
  • 9. Moyer, J. H.; Fuchs, M.; Irie, S.; Bodi, T. Some observations on the pharmacology of hydrochlorothiazide. Am. J. Cardiol. 1959, 1, 113–7. https://doi.org/10.1016/0002-9149(59)90402-3.
  • 10. Grahame Smith, J. A. D. G. Clinical Pharmacology and Drug Therapy, 3rd edition; Oxford University Press, 2002.
  • 11. Beermann, B.; Groschinsky-Grind, M.; Rosén, A. Absorption, metabolism, and excretion of hydrochlorothiazide. Clin. Pharmacol. Ther. 1976, 19(5), 531–7, PART 1. https://doi.org/10.1002/cpt1976195part1531.
  • 12. Shammas, F. V.; Dickstein, K. Clinical pharmacokinetics in heart failure: an updated review. Clin. Pharmacokinet. 1988, 15(2), 94–113. https://doi.org/10.2165/00003088-198815020-00002.
  • 13. Medvedovici, A.; Mircioiu, C.; David, V.; Miron, D. S. Liquid extraction and HPLC-DAD assay of hydrochlorothiazide from plasma for a bioequivalence study at the lowest therapeutic dose. Eur. J. Drug Metab. Pharmacokinet. 2000, 25(2), 1–96. https://doi.org/10.1007/BF03190073.
  • 14. Beermann, B.; Groschinsky-Grind, M. Pharmacokinetics of hydrochlorothiazide in man. Eur. J. Clin. Pharmacol. 1977, 12(4), 297–303. https://doi.org/10.1007/BF00607430.
  • 15. Rang & Dale’s Rang & Dale’s Pharmacology, 9th edition; Elsevier, 2020.
  • 16. Andrade-Eiroa, A.; Canle, M.; Leroy-Cancellieri, V.; Cerdà, V. Solid-phase extraction of organic compounds: a critical review (Part I). TrAC - Trends Anal. Chem. 2016, 80, 641–54. https://doi.org/10.1016/j.trac.2015.08.015.
  • 17. Simpson, N. J. K. Solid-Phase Extraction: Principles, Techniques, and Applications, 1980.
  • 18. Campíns-Falcó, P.; Herráez-Hernández, R.; Sevillano-Cabeza, A. Solid-phase extraction techniques for assay of diuretics in human urine samples. J. Liq. Chromatogr. 1991, 14(19), 3575–90. https://doi.org/10.1080/01483919108049412.
  • 19. Komal Arora, H. V. Gangadharappa, UPASS-WINTER-2015.pdf. Int. J. Pharm. Sci. Res. 2016, 7(6), 2291–301. https://doi.org/10.13040/IJPSR.0975-8232.7(6).2291-01.
  • 20. Medvedovici, A.; Bacalum, E.; David, V. Sample preparation for large-scale bioanalytical studies based on liquid chromatographic techniques. Biomed. Chromatogr. Jan. 2018, 32(1), 4137. https://doi.org/10.1002/bmc.4137.
  • 21. Treybal, R. E. Liquid extraction. Ind. Eng. Chem. Mar. 1956, 48(3), 510–9. https://doi.org/10.1021/ie51399a010.
  • 22. Foster, P. R. Engineering Processes for Bioseparations, 1st ed.; Elsevier, 1994.
  • 23. Novák, P.; Havlí_cek, V. Protein extraction and precipitation. Proteomic Profiling Anal. Chem. Crossroads Second Ed. 2016, 52–62. https://doi.org/10.1016/B978-0-444-63688-1.00004-5.
  • 24. Zendelovska, D.; Stafilov, T.; Milo_sevski, P. Development of solidphase extraction method and its application for determination of hydrochlorothiazide in human plasma using HPLC. Biomed. Chromatogr. 2004, 18(2), 71–6. https://doi.org/10.1002/bmc.293.
  • 25. Pei, B. F.; Guo, H.; Zheng, L.-C.; Qiu, J. F.; Chen, H.-Y. Determination of hydrochlorthiazide in human plasma by hplc: application to a pharmacokinetic study. Lat. Am. J. Pharm. 2014, 33(9), 1470–4, [Online]. Available www.latamjpharm.org/resumenes/33/9/LAJOP_33_9_1_9.pdf.
  • 26. Sun, Y.; Wei, Y.; Wang, K.; Shao, Q. HPLC determination of hydrochlorothiazide in human plasma. Yaowu Fenxi Zazhi 2010, 30(3), 396–8.
  • 27. Wang, R. Determination of hydrochlorothiazide in healthy human plasma and its pharmacokinetic study. Zhongguo Yaoye 2011, 20(23), 17–8.
  • 28. Richter, K.; Oertel, R.; Kirch, W. New sensitive method for the determination of hydrochlorothiazide in human serum by highperformance liquid chromatography with electrochemical detection. J. Chromatogr. A. 1996, 729(1–2), 293–6. https://doi.org/10.1016/0021-9673(95)00900-0.
  • 29. Farthing, D.; Fakhry, I.; Ripley, E. B. D.; Sica, D. Simple method for determination of hydrochlorothiazide in human urine by high performance liquid chromatography utilizing narrowbore chromatography. J. Pharm. Biomed. Anal. 1998, 17(8), 1455–9. https://doi.org/10.1016/S0731-7085(98)00021-1.
  • 30. Alvi, S. N.; Faisal, K.; Hospital, S.; Hammami, M. M.; Faisal, K.; Hospital, S. A validated reversed-phase HPLC method for the determination of hydrochlorothiazide in human plasma. Am. J. Pharmatech Res. 2015, 5(2), 445–54.
  • 31. Rajasekhar, D.; Kumar, I. J.; Venkateswarlu, P. A high-performance liquid chromatography/negative ion electrospray tandem mass spectrometry method for the determination of hydrochlorothiazide in human plasma: application to a comparative bioavailability study. Eur. J. Mass Spectrom. 2009, 15(6), 715–21. https://doi.org/10.1255/ejms.1038.
  • 32. Sousa, C. E. M. Rapid determination of hydrochlorothiazide in human plasma by high performance liquid chromatography-tandem mass spectrometry. Lat. Am. J. Pharm. 2009, 28(5), 793–7.
  • 33. Fang, W.; Xie, W.; Hsieh, J. Y. K.; Matuszewski, B. K. Development and application of HPLC methods with tandem mass spectrometric detection for the determination of hydrochlorothiazide in human plasma and urine using 96-well liquid-liquid extraction. J. Liq. Chromatogr. Relat. Technol. 2005, 28(17), 2681–703. https://doi.org/10.1080/10826070500224666.
  • 34. Miller, R. B.; Amestoy, C. A liquid chromatographic method for the determination of hydrochlorothiazide in human plasma. J. Pharm. Biomed. Anal. 1992, 10(7), 541–5. https://doi.org/10.1016/0731-7085(92)80078-2.
  • 35. Li, L.; Sun, J.; Yang, P.; He, Z. Liquid chromatography-electrospray ionization-mass spectrometric method for the determination of hydrochlorothiazide in human plasma: application to a pharmacokinetic study. Anal. Lett. 2006, 39(15), 2797–807. https://doi.org/10.1080/00032710600867465.
  • 36. Ramakrishna, N. V. S.; Vishwottam, K. N.; Manoj, S.; Koteshwara,M.; ishu, S.; Varma, D. P. Sensitive liquid chromatography-tandem mass spectrometry method for quantification of hydrochlorothiazide in human plasma. Biomed. Chromatogr. 2005, 19(10), 751–60. https://doi.org/10.1002/bmc.510.
  • 37. Liu, F.; Xu, Y.; Gao, S.; zhang, J.; Guo, Q. Determination of hydrochlorothiazide in human plasma by liquid chromatography/ tandem mass spectrometry. J. Pharm. Biomed. Anal. 2007, 44(5), 1187–91. https://doi.org/10.1016/j.jpba.2007.04.020.
  • 38. Wang, Q.; Ding, F.; Li, H.; He, P.; Fang, Y. Determination of hydrochlorothiazide and rutin in Chinese herb medicines and human urine by capillary zone electrophoresis with amperometric detection. J. Pharm. Biomed. Anal. 2003, 30(5), 1507–14. https://doi.org/10.1016/S0731-7085(02)00540-X.
  • 39. Haque, S. K. M. Box–Behnken experimental design for optimizing the HPLC method to determine hydrochlorothiazide in pharmaceutical formulations and biological fluid. J. Mol. Liq. 2022, 352, 118708. https://doi.org/10.1016/j.molliq.2022.118708.
  • 40. Sethi, P. D. Qualitative Analysis of Pharmaceutical Formulations, 7th edition; S.K. Jain for CBS Publishers and Distribution, 2001.
  • 41. Kasture, V.; Patil, P.; Pawar, S.; Gudaghe, V. Department, geometrical correction method for estimation of hydrochlorothiazide. INDO Am. J. Pharm. Res. 2013, 3(9).
  • 42. Shang, D. Simultaneous determination of nitrendipine and hydrochlorothiazide in spontaneously hypertensive rat plasma using HPLC with on-line solid-phase extraction. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2011, 879(30), 3459–64. https://doi.org/10.1016/j.jchromb.2011.09.025.
  • 43. Özkan, S. A. Simultaneous determination of losartan potassium and hydrochlorothiazide from tablets and human serum by RPHPLC. J. Liq. Chromatogr. Relat. Technol. 2001, 24(15), 2337–46. https://doi.org/10.1081/JLC-100105145.
  • 44. Vujić, Z.; Crevar, M.; Obradović, V.; Kuntić, V.; Uskoković-Marković, S. Simultaneous determination of hydrochlorthiazide, cilazapril and its active metabolite cilazaorilat in urine by gradient RP-LC. Springer 2009, 70, 1221–5.
  • 45. Tutunji, L. F.; Tutunji, M. F.; Alzoubi, M. I.; Khabbas, M. H.; Arida, A. I. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectrometry: application to bioequivalence studies. J. Pharm. Biomed. Anal. 2010, 51(4), 985–90. https://doi.org/10.1016/j.jpba.2009.10.023.
  • 46. Elgawish, S. M.; Mostafa, M. S.; Elshanawane, A. A. HPLC method for simultaneous determination of amiloride hydrochloride and hydrochlorothiazide in human plasma, Egypt. J. Pharm. Sci. 2009, 50, 147–58.
  • 47. Aydoǧmus¸, Z. Simultaneous determination of aliskiren, amlodipine and hydrochlorothiazide in spiked human plasma and urine by high performance liquid chromatography. J. Anal. Chem. 2015, 70(4), 502–9. https://doi.org/10.1134/S1061934815040176.
  • 48. Samya, A. M. A.-M.; El-Gizaw, M.; Abdelmageed, O. H.; Omar, M. A.; Deryea, S. M. Development and validation of HPLC method for simultaneous determination of amlodipine, valsartan, hydrochlorothiazide in dosage form and spiked human plasma Samya. Dhaka Univ. J. Pharm. Sci. 2012, 3(1), 422–30. https://doi.org/10.3329/dujps.v13i1.21859.
  • 49. Sharma, R. N.; Pancholi, S. S. Simple RP-HPLC method for determination of triple drug combination of valsartan, amlodipine and hydrochlorothiazide in human plasma. Acta Pharm. 2012, 62(1), 45–58. https://doi.org/10.2478/v10007-012-0004-3.
  • 50. Erk, N. Simultaneous analysis of candesartan cilexetil and hydrochlorothiazide in human plasma and dosage forms using HPLC with a photodiode array detector. J. Liq. Chromatogr. Relat. Technol. 2003, 26(15), 2581–91. https://doi.org/10.1081/JLC-120023802.
  • 51. Foda, N. H.; Naeem, O.; Elbary, A. A.; Elbary, G. A. Simultaneous HPLC determination of enalapril and hydrochlorothiazide in human plasma and its pharmacokinetic application. J. Pharm. Sci. Res. 2010, 2(11), 786–94.
  • 52. Tolba, M. M.; Belal, F.; El-Brashy, A. M.; El-Enany, N. Liquid chromatographic method for the simultaneous determination of Eprosartan and hydrochlorothiazide in tablets and human plasma. J. aoaC Int. 2011, 94(3), 823–32.
  • 53. Nagwa, A. Simultaneous determination of irbesartan and hydrochiorothiazide in human plasma by high performance liquid chromatography and its pharmacokinetic application, New Egypt. J. Med. 2003, 784(1), 195–201. https://doi.org/10.1016/S1570-0232(02)00759-6.
  • 54. Sultana, N.; Arayne, M. S.; Ali, S. S.; Sajid, S. Simultaneous determination of olmesartan medoxomil and irbesartan and hydrochlorothiazide in pharmaceutical formulations and human serum using high performance liquid chromatography. Chin. J. Chromatogr. (Se Pu) 2008, 26(5), 544–9. https://doi.org/10.1016/s1872-2059(08)60029-2.
  • 55. Li, H. Simultaneous determination of hydrochlorothiazide and reserpine in human urine by LC with a simple pre-treatment. Chromatographia 2011, 73(1–2), 171–5. https://doi.org/10.1007/s10337-010-1821-5.
  • 56. Salama, I. Simultaneous HPLC–UV analysis of telmisartan and hydrochlorothiazide in human plasma. Bull. Fac. Pharmacy, Cairo Univ. 2011, 49(1), 19–24. https://doi.org/10.1016/j.bfopcu.2011.07.005.
  • 57. Huang, T.; He, Z.; Yang, B.; Shao, L.; Zheng, X.; Duan, G. Simultaneous determination of captopril and hydrochlorothiazide in human plasma by reverse-phase HPLC from linear gradient elution. J. Pharm. Biomed. Anal. 2006, 41(2), 644–8. https://doi.org/10.1016/j.jpba.2005.12.007.
  • 58. Kepekci Tekkeli, S. E. Development of an HPLC-UV method for the analysis of drugs used for combined hypertension therapy in pharmaceutical preparations and human plasma. J. Anal. Methods Chem. 2013, 2013. https://doi.org/10.1155/2013/179627.
  • 59. Sultan, M.; Abdine, H.; Zoman, N.; Belal, F. High performance liquid chromatoqraphic method for the simultaneous determination of labetalol and hydrochlorothiazide in tablets and spiked human plasma. Sci. Pharm. 2004, 72(2), 143–55. https://doi.org/10.3797/scipharm.aut-04-13.
  • 60. Lei, X.; Zeng, Z.; Lu, H.; He, C.; Zhong, X. Simultaneous determination of hydrochlorothiazide and olmesartan in human plasma by HPLC–《Chinese Journal of Clinical Pharmacy》2010 年02期. Chin. J. Clin. Pharm. 2010, 101, [Online]. Available: http://en.cnki.com.cn/Article_en/CJFDTOTAL-LCZZ201002011.htm.
  • 61. Telugu, G.; Suresh, P. V. Bioanalytical method development and validation of Eprosartan mesylate and hydrochlorthiazide using RP-HPLC in human plasma. Res. J. Pharm. Technol. 2023, 16(3), 1095–9. https://doi.org/10.52711/0974-360X.2023.00182.
  • 62. Mahadik Sathiyanarayanan, Instrumental Method of Analysis, 1st ed. Nirali Prakashan, 2020.
  • 63. Rote, A. R.; Sonavane, P. R. Bioanalytical method development and validation for determination of metoprolol tartarate and hydrochlorothiazide using HPTLC in human plasma. Braz. J. Pharm. Sci. 2013, 49(4), 845–51. https://doi.org/10.1590/S1984-82502013000400025.
  • 64. Pandya, J. J.; Bhatt, N. M.; Chavada, V. D.; Sharma, P.; Sanyal, M.; Shrivastav, P. S. Simultaneous analysis of aliskiren and hydrochlorothiazide in pharmaceutical preparations and spiked human plasma by HPTLC. J. Taibah Univ. Sci. 2017, 11(5), 667–76. https://doi.org/10.1016/j.jtusci.2016.05.001.
  • 65. Bebawy, L. I.; Abbas, S. S.; Fattah, L. A.; Refaat, H. H. Application of first-derivative, ratio derivative spectrophotometry, TLCdensitometry and spectrofluorimetry for the simultaneous determination of telmisartan and hydrochlorothiazide in pharmaceutical dosage forms and plasma. Farmaco 2005, 60(10), 859–67. https://doi.org/10.1016/j.farmac.2005.06.009.
  • 66. Rote, A. R.; Sonavane, P. R. Development and validation of bioanalytical method for determination of telmisartan and hydrochlorothiazide using HPTLC in human plasma. Am. J. Anal. Chem. 2012, 03(11), 774–8. https://doi.org/10.4236/ajac.2012.311103.
  • 67. Pandya, J. J.; Sanyal, M.; Shrivastav, P. S. Simultaneous densitometric analysis of amlodipine, hydrochlorothiazide, lisinopril, and valsartan by HPTLC in pharmaceutical formulations and human plasma. J. Liq. Chromatogr. Relat. Technol. 2017, 40(9), 467–78. https://doi.org/10.1080/10826076.2017.1324482.
  • 68. Belal, F.; Walash, M.; El-Enany, N.; Zayed, S. Simultaneous determination of aliskiren and hydrochlorothiazide in tablets and spiked human urine by ion-pair liquid chromatography. Pharmazie 2013, 68(12), 933–8. https://doi.org/10.1691/ph.2013.3023.
  • 69. Rambla-Alegre, M. Basic principles of MLC. Chromatogr. Res. Int. 2012, 1–6, 2012 https://doi.org/10.1155/2012/898520.
  • 70. Shankar Ganesha, R. S. G.; Demeb, P.; Madhusudanaa, K. Simultaneous determination of amlodipine, valsartan and hydrochlorothiazide by LC-ESI-MS/MS and its application to pharmacokinetics in rats. J. Pharm. Anal. 2014, 4(6), 399–406. https://doi.org/10.1016/j.jpha.2013.12.003.
  • 71. Said, R.; Arafat, B.; Arafat, T.; Mallah, E. An LC-MS/MS method for determination of triple drugs combination of valsartan, amlodipine and hydrochlorothiazide in human plasma for bioequivalence study. Curr. Pharm. Anal. 2019, 17(2), 241–53. https://doi.org/10.2174/1573412916666191111125807.
  • 72. Jangid, A. G.; Tale, R. H.; Vaidya, V. V. A single, selective and simple validated method for simultaneous estimation of amiloride and hydrochlorothiazide in human plasma by liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 2012, 26(1), 95–100. https://doi.org/10.1002/bmc.1632.
  • 73. Salvadori, M. C. Simultaneous determination of losartan and hydrochlorothiazide in human plasma by LCMSMS with electrospray ionization and its application to pharmacokinetics. Clin. Exp. Hypertens. 2009, 31(5), 415–27. https://doi.org/10.1080/10641960802668714.
  • 74. Song M., Hang T., Zhao H., Wang L., Ge P., & Ma P., Simultaneous determination of amiloride and hydrochlorothiazide in human plasma by liquid chromatography/tandem mass spectrometry with positive/negative ion-switching electrospray ionisation Min. Rapid Commun. Mass Spectrom. 2007, 21, 3427–34. https://doi.org/10.1002/rcm.
  • 75. Shah, J. V.; Shah, P. A.; Shah, P. V.; Sanyal, M.; Shrivastav, P. S. Fast and sensitive LC–MS/MS method for the simultaneous determination of lisinopril and hydrochlorothiazide in human plasma. J. Pharm. Anal. 2017, 7(3), 163–9. https://doi.org/10.1016/j.jpha.2016.11.004.
  • 76. Brushinina, O. S. Determination of candesartan and hydrochlorothiazide in human plasma by HPLC coupled with mass spectrometry. Int. J. Anal. Mass Spectrom. Chromatogr. 2014, 02(02), 25–32. https://doi.org/10.4236/ijamsc.2014.22003.
  • 77. Bonthu, M. G.; Atmakuri, L. R.; Jangala, V. R. Simultaneous determination of candesartan and hydrochlorothiazide in human plasma by LC-MS/MS. Braz. J. Pharm. Sci. 2018, 54(1), 1–10. https://doi.org/10.1590/s2175-97902018000117381.
  • 78. Bharathi, D. V.; Hotha, K. K.; Chatki, P. K.; Satyanarayana, V.; Venkateswarlu, V. LC-MS/MS method for simultaneous estimation of candesartan and hydrochlorothiazide in human plasma and its use in clinical pharmacokinetics. Bioanalysis 2012, 4(10), 1195–204. https://doi.org/10.4155/bio.12.83.
  • 79. Zhang, R. R. Liquid chromatography coupled with mass spectrometry method for the simultaneous quantification of irbesartan and hydrochlorothiazide in human plasma. J. Chin. Pharm. Sci. 2011, 20(4), 360–7. https://doi.org/10.5246/jcps.2011.04.045.
  • 80. Kishore, D.; Jain, P.; Bhardwaj, Y. R. A liquid chromatography tandem mass spectrometry based method for the simultaneous determination of irbesartan and hydrochlorthiazide in human plasma. Int. J. Drug Dev. Res. 2014.
  • 81. Lu, L. Simultaneous determination and pharmacokinetics of irbesartan and hydrochlorothiazide in human plasma by LC-MS/MS. Zhongguo Xinyao Yu Linchuang Zazhi 2012, 31(1), 50–4.
  • 82. Qiu, X.; Wang, Z.; Wang, B.; Zhan, H.; Pan, X.; Ai Xu, R. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by ultra high performance liquid chromatography tandem mass spectrometry and its application to a bioequivalence study. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2014, 957, 110–5. https://doi.org/10.1016/j.jchromb.2014.03.002.
  • 83. Gao, F.; Zhang, M.; Cui, X.; Wang, Z.; Sun, Y.; Gu, J. Simultaneous quantitation of hydrochlorothiazide and metoprolol in human plasma by liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2010, 52(1), 149–54. https://doi.org/10.1016/j.jpba.2009.12.012.
  • 84. Vespasiano, C. F. P.; Laurito, T. L.; Iwamoto, R. D.; Moreno, R. A.; Mendes, G. D.; De Nucci, G. Bioequivalence study between a fixed-dose single-pill formulation of nebivolol plus hydrochlorothiazide and separate formulations in healthy subjects using highperformance liquid chromatography coupled to tandem mass spectrometry. Biomed. Chromatogr. 2017, 31, 5. https://doi.org/10.1002/bmc.3884.
  • 85. Sora, I.; Cristea, E.; Albu, F.; Udrescu, S.; David, V.; Medvedovici, A. LC-MS/MS assay of quinapril and its metabolite quinaprilat for drug bioequivalence evaluation: prospective, concurrential and retrospective method validation. Bioanalysis 2009, 1(1), 71–86. https://doi.org/10.4155/bio.09.5.
  • 86. Patel, J. R.; Pethani, T. M.; Vachhani, A. N.; Sheth, N. R.; Dudhrejiya, A. V. Development and validation of bioanalytical method for simultaneous estimation of ramipril and hydrochlorothiazide in human plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2014, 970, 53–9. https://doi.org/10.1016/j.jchromb.2014.08.023.
  • 87. Patel, B.; Jangid, A. G.; Suhagia, B. N.; Desai, N. Challenges in simultaneous determination of hydrochlorothiazide and ramipril in human plasma: application to a bioequivalence study. J. Chromatogr. Sci. 2018, 56(10), 867–78. https://doi.org/10.1093/chromsci/bmy055.
  • 88. George, M.; Joseph, L.; Jain, A. K.; A. V. Bioanalytical method development and validation of simultaneous analysis of telmisartan and hydrochlorthiazide in human plasma using LC-MS/MS. Int. J. Bioassays 2016, 5(03), 862. https://doi.org/10.21746/ijbio.2016.03.003.
  • 89. Yan, T. Liquid chromatographic-tandem mass spectrometric method for the simultaneous quantitation of telmisartan and hydrochlorothiazide in human plasma. J. Pharm. Biomed. Anal. 2008, 48(4), 1225–9. https://doi.org/10.1016/j.jpba.2008.08.021.
  • 90. Margaryan, T.; Mikayelyan, A.; Zakaryan, H.; Armoudjian, Y.; Alaverdyan, H. Simultaneous determination of Triamterene and Hydrochlorothiazide in human plasma by liquid chromatography tandem mass spectrometry and its application to a bioequivalence study. SN Appl. Sci. 2019, 1(6), 1–11. https://doi.org/10.1007/s42452-019-0672-4.
  • 91. Liu, F.; Zhang, J.; Xu, Y.; Gao, S.; Guo, Q. Simultaneous determination of hydrochlorothiazide and valsartan in human plasma by liquid chromatography/tandem mass spectrometry. Anal. Lett. 2008, 41(8), 1348–65. https://doi.org/10.1080/000327/10802119186.
  • 92. Li, H. A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007, 852(1–2), 436–42. https://doi.org/10.1016/j.jchromb.2007.02.014.
  • 93. Shah, H. J.; Kataria, N. B.; Subbaiah, G.; Patel, C. N. Simultaneous LC-MS-MS Analysis of Valsartan and Hydrochlorthiazide in Human Plasma. Springer 2009, 69(2009), 1055–60.
  • 94. Gonzalez, O. LC-MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2010, 878(28), 2685–92. https://doi.org/10.1016/j.jchromb.2010.07.026.
  • 95. Tutunji, M. F.; Ibrahim, H. M.; Khabbas, M. H.; Tutunji, L. F. Simultaneous determination of bisoprolol and hydrochlorothiazide in human plasma by HPLC coupled with tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2009, 877(16–17), 1689–97. https://doi.org/10.1016/j.jchromb.2009.04.021.
  • 96. Mohammad, M. A. A.; Mahrouse, M. A.; Amer, E. A. H.; Elharati, N. S. Validated LC–MS/MS method for the simultaneous determination of enalapril maleate, nitrendipine, hydrochlorothiazide, and their major metabolites in human plasma. Biomed. Chromatogr. 2020, 34(12), 1–11. https://doi.org/10.1002/bmc.4955.
  • 97. Kolocouri, F.; Dotsikas, Y.; Apostolou, C.; Kousoulos, C.; Loukas, Y. L. Simultaneous determination of losartan, EXP-3174 and hydrochlorothiazide in plasma via fully automated 96-wellformat- based solid-phase extraction and liquid chromatographynegative electrospray tandem mass spectrometry. Anal. Bioanal. Chem. 2007, 387(2), 593–601. https://doi.org/10.1007/s00216-006-0990-4.
  • 98. Ongas, M. O. LC–MS/MS method for quantitation of hydrochlorothia- zide and nifedipine in human plasma. ABC Res. Alert 2018, 6, 3. https://doi.org/10.18034/abcra.v6i3.333.
  • 99. Elkady, E. F.; Mandour, A. A.; Algethami, F. K.; Aboelwafa, A. A.; Farouk, F. Sequential liquid-liquid extraction coupled to LC-MS/MS for simultaneous determination of amlodipine, olmesartan and hydrochlorothiazide in plasma samples: application to pharmacokinetic studies. Microchem. J. 2020, 155, 104757, December 2019 https://doi.org/10.1016/j.microc.2020.104757.
  • 100. Parekh, S. A.; Pudage, A.; Joshi, S. S.; Vaidya, V. V.; Gomes, N. A.; Kamat, S. S. Simultaneous determination of hydrochlorothiazide, quinapril and quinaprilat in human plasma by liquid chromatography- tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2008, 873(1), 59–69. https://doi.org/10.1016/j.jchromb.2008.07.046.
  • 101. Devalapalli, M. M. R.; Cheruvu, H. S.; Yertha, T.; Veeravalli, V. B.; Sampathi, S.; Shivakumar, S. Hansen solubility parameters for assay method optimization of simvastatin, ramipril, atenolol, hydrochlorothiazide and aspirin in human plasma using liquid chromatography with tandem mass spectrometry. J. Sep. Sci. 2017, 40(18), 3662–74. https://doi.org/10.1002/jssc.201700565.
  • 102. Dubey, R.; Ghosh, M. Simultaneous determination and pharmacokinetic study of losartan, losartan carboxylic acid, ramipril, ramiprilat, and hydrochlorothiazide in rat plasma by a liquid chromatography/tandem mass spectrometry method. Sci. Pharm. 2015, 83(1), 107–24. https://doi.org/10.3797/scipharm.1410-15.
  • 103. Goswami, D. Pharmacokinetic estimation of losartan, losartan carboxylic acid and hydrochlorothiazide in human plasma by LC/MS/MS validated method. Clin. Res. Regul. Aff. 2008, 25(4), 235–58. https://doi.org/10.1080/10601330802600901.
  • 104. Kumar, A.; Prasad Verma, P. R.; Monif, T.; Khuroo, A. H.; Iyer, S. S. Development and validation of a LC-ESI-MS/MS method for simultaneous quantification of olmesartan and hydrochlothiazide in human K3 EDTA plasma and its application to pharmacokinetic biostudy. Clin. Res. Regul. Aff. 2014, 31(1), 6–23. https://doi.org/10.3109/10601333.2013.849267.
  • 105. Kumar, A.; Verma, P. R. P.; Monif, T.; Khuroo, A. H.; Iyer, S. S.; Singh, A. K. Challenges in bioanalytical method development for simultaneous determination of olmesartan and hydrochlorothiazide in human plasma by liquid chromatography coupled to tandem mass spectrometry. J. Liq. Chromatogr. Relat. Technol. 2012, 35(1), 59–78. https://doi.org/10.1080/10826076.2011.597060.
  • 106. Liu, D.; Jiang, J.; Wang, P.; Feng, S.; Hu, P. Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2010, 878(9–10), 743–8. https://doi.org/10.1016/j.jchromb.2010.01.009.
  • 107. Kumar, A.; Dwivedi, S. P.; Prasad, T. Method validation for simultaneous quantification of olmesartan and hydrochlorothiazide in human plasma using LC-MS/MS and its application through bioequivalence study in healthy volunteers. Front. Pharmacol. 2019, 10(July), 1–13. https://doi.org/10.3389/fphar.2019.00810.
  • 108. Haque, A.; Iqbal, M.; Alamoudi, M. K.; Alam, P. A selective and accurate LC-MS/MS method for simultaneous quantification of valsartan and hydrochlorothiazide in human plasma. Separations 2023, 10(2), 119, 2023. https://doi.org/10.3390/separations10020119.
  • 109. Nazareth, C.; Pereira, S.; Batheja, R. A sensitive, economical bioanalytical lc-ms/ms method for simultaneous analysis of irbesartan and hydrochlorothiazide. Indian Drugs 2023, 60(6), 55–65.
  • 110. Hapse, S. A.; Wagh, V. S.; Kadaskar, P. T.; Dokhe, M. D.; Shirsath, A. S. Spectrophotometric estimation and validation of hydrochlorothiazide in tablet dosage forms by using different solvents. Der Pharma Chemica 2012, 4(1), 10–4.
  • 111. Amir Ashraf, S.; Nazir, S.; Adnan, M.; Azad, Z. R. A. A. UPLC-MS: an emerging novel technology and its application in food safety. Anal. Chem. - Adv. Perspect. Appl. une. 2021, 1–19. https://doi.org/10.5772/intechopen.92455.
  • 112. Khan Hamid, A. J.; Ali, M.; Ahuja, A. Validated UPLC/Q-TOFMS method for simultaneous determination of telmisartan and hydrochlorothiazide in human plasma. Res. J. Pharm. Technol. 2016, 9(9), 3178.
  • 113. Alam, M. A.; Abou Obaid, N. I.; Ibrahim, M. A.; Raish, M.; Al-Jenoobi, F. I. A validated ultra-performance liquid chromatography tandem triple quadrupole mass spectrometric method for fast determination of losartan in rabbit plasma. J. Chromatogr. Sci. 2019, 57(4), 323–30. https://doi.org/10.1093/chromsci/bmy114.
  • 114. Shah, P. A.; Sharma, P.; Shah, J. V.; Sanyal, M.; Shrivastav, P. S. Simultaneous analysis of losartan, its active metabolite, and hydrochlorothiazide in human plasma by a UPLC-MS/MS method. Turkish J. Chem. 2015, 39(4), 714–33. https://doi.org/10.3906/kim-1502-4.
  • 115. Zargar, S.; Wani, T. A. New UPLC-MS/MS method for simultaneous determination of irbesartan and hydrochlorthiazide in human plasma. J. Iran. Chem. Soc. 2014, 11(6), 1579–86. https://doi.org/10.1007/s13738-014-0429-3.
  • 116. De Nicolò, A. UHPLC–MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. J. Pharm. Biomed. Anal. 2017, 142, 279–85. https://doi.org/10.1016/j.jpba.2017.05.018.
  • 117. De Nicolò, A. UHPLC–MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients. J. Pharm. Biomed. Anal. 2016, 129, 535–41. https://doi.org/10.1016/j.jpba.2016.07.049.
  • 118. Ebeid, W. M.; Elkady, E. F.; El-Zaher, A. A.; El-Bagary, R. I.; Patonay, G. Simultaneous determination of aliskiren hemifumarate, amlodipine besylate and hydrochlorothiazide in spiked human plasma using UPLC-MS/MS. J. Chromatogr. Sci. 2015, 53(7), 1178–84. https://doi.org/10.1093/chromsci/bmu213.
  • 119. Perkampus, H.-H. UV-VIS Spectroscopy and its Applications; Springer, 1992.
  • 120. Silva, E. F.; Tanaka, A. A.; Fernandes, R. N.; Munoz, R. A. A.; da Silva, I. S. Batch injection analysis with electrochemical detection for the simultaneous determination of the diuretics furosemide and hydrochlorothiazide in synthetic urine and pharmaceutical samples. Microchem. J. 2020, 157(May), 105027. https://doi.org/10.1016/j.microc.2020.105027.
  • 121. Tiris, G.; Mehmandoust, M.; Lotfy, H. M.; Erk, N.; Joo, S. W.; Dragoi, E.; Vasseghian, Y. Simultaneous determination of hydrochlorothiazide, amlodipine, and telmisartan with spectrophotometric and HPLC green chemistry applications. Chemosphere. 2022, 303(3), 135074. https://doi.org/10.1016/j.chemosphere.2022.135074.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-9f69b867-b6c5-4377-bd46-4b76a72906e1
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.